New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2013
07:21 EDTZMHZimmer sees FY13 adjusted EPS $5.65-$5.85, consensus $5.74
Sees FY13 revenue up 2.5%-4.5% on constant currency basis, consensus $4.63B. The Company estimates that foreign currency translation will decrease revenues by approximately 0.5% for the full year 2013, resulting in reported revenue growth between 2% and 4%. In 2013, the Company expects to continue global restructuring and transformation initiatives designed to streamline business operations and support functions. Savings from these initiatives will enable the Company to absorb the medical device excise tax, continue to support investments in innovation and commercialization of new products and technologies, expand global sales channels and drive sustained growth in earnings and cash flow. The programs to be completed in 2013 are expected to generate annualized pre-tax savings of more than $80 million, including $30 million to $40 million to be realized in 2013.
News For ZMH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
15:17 EDTZMHZimmer Acquires bone void filler maker ETEX Holdings
Zimmer Holdings announced that it has acquired the business of ETEX Holdings. The financial terms of the transaction were not disclosed. The acquisition enhances Zimmer's Biologics portfolio of treatments through the addition of ETEX's Beta-bsm, CarriGen, EquivaBone, and Gamma-bsm bone void filler products.
September 18, 2014
09:32 EDTZMHMiMedx signs distribution agreement with Zimmer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use